Patrick Smerkers - Profile and Investment Details

Investor Profile

Patrick Smerkers is a Venture Capital, Private Equity Firm based in Baltimore, Maryland, United States with a diverse investment portfolio that includes companies such as Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences, Ori Biotech, Candel, Scitara, SeLux Diagnostics, General Automation Lab Technologies, Personal Genome Diagnostics, Artisan Bio, Ultivue, Sherlock Biosciences, StrideBio, Intabio, Inflammatix, Codex DNA, Refeyn, Encodia, Aro Biotherapeutics, SpeeDx, Triumvira Immunologics, Vestaron, Scipher Medicine, IsoPlexis, Delfi Diagnostics, ChromaCode, Vizgen, DiCE Molecules, Octave Bioscience, Hawthorne Effect, 908 Devices, DNAnexus, Teckro. Over time, Patrick Smerkers has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Patrick Smerkers is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Alternative Medicine, Women Founded, Medical Testing, Women Led, Test and Measurement, Artificial Intelligence (AI), Information Technology (IT), Biotech, Analytics, Medical Device, Bioinformatics, Software, Healthcare, Biotechnology, Home Care, Health Diagnostics, Medical, Big Data, Therapeutics, Media and Entertainment, Personal Health, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Patrick Smerkers, as their portfolio suggests a familiarity and interest in this area.

Understanding Patrick Smerkers’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.